INTERNATIONAL PATENT: CAPTOR THERAPEUTICS S.A. FILES APPLICATION FOR "TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET PROTEIN KINASE C"

GENEVA, July 3 -- CAPTOR THERAPEUTICS S.A. (ul. Duńska 1154-427 Wroclaw) filed a patent application (PCT/PL2023/000065) for "TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET PROTEIN KINASE C" on Dec 22, 2023. With publication no. WO/2025/136129, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): COTTENS, Sylvain (Traubenweg 344108 Witterswil), FOREITER, Magdalena (ul. Leśmiana 244-200 Rybnik), KACZANOWSKA, Katarzyna (ul. Tęczowa 89/5053-601 Wrocław), SHISHOV,...